Dopamine selectively modulates lipopolysaccharide-induced TNF-alpha, IFN-qamma and IL-10 within mice tissues

Neuroendocrinology Letters

Volumn 32, Issue 2, 2011, Pages 176-186

  Matalka, Khalid Z ^a   Attallah, Lama J ^a   Qinna, Nidal A ^a   Alhussainy, Tawfiq ^a  

^a UNIVERSITY OF PETRA   (Jordan)

Author keywords

Cytokine modulation; Cytokines; Dopamine; Dopamine antagonists; IFN ; IL 10; Tissues; TNF

Indexed keywords

CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; GAMMA INTERFERON; HALOPERIDOL; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; LIVER; LUNG; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN BLOOD LEVEL; SPLEEN;

EID: 80051612395     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Abbas AK, Murphy KM, Sher A (1996) A functional diversity of helper T lymphocytes. Nature. 383: 787-93.
2. Abraham E, Arcaroli J, Shenkar R (2001) Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5′- monophosphate response element-binding protein in lung neutrophils occurs by different mechanisms after hemorrhage or endotoxemia. J Immunol. 166: 522-530. (Pubitemid 32038472)
3. Bacic F, Uematsu S, McCarron RM, Spatz M (1991) Dopaminergic receptors linked to adenylate cyclase in human cerebrovascular endothelium. J Neurochem. 57: 1774-1780. (Pubitemid 21922818)
4. Basu S, Dasgupta PS (2000) Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol. 102: 113-124.
5. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, et al (2001) The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 7: 569-574. (Pubitemid 32448324)
6. Beck GC, Brinkkoetter P, Hanusch C, Schulte J, Ackern KV, Woude FD, et al (2004) Clinical review: Immunomodulatory effects of dopamine in general inflammation. Crit Care. 8: 485-491. (Pubitemid 40073684)
7. Bergquist J, Ohlsson B, Tarkowski A (2000) Nuclear factor kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann NY Acad Sci. 917: 281-289.
8. Besser MJ, Ganor Y, Levite M (2005) Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF α or both. J Neuroimmunol. 169: 161-171. (Pubitemid 41528789)
9. Brenner S, Prosch S, Schenke-Layland K, Riese U, Gausmann U, Platzer C (2003) cAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J Biol Chem. 278: 5597-5604. (Pubitemid 36800801)
10. Cosentino M, Zaffaronic M, Ferraria M, Marino F, Bombellia R, Rasinia E, et al (2005) Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells: Implications for multiple sclerosis. J Neuroimmunol. 162: 112-121.
11. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 362: 779-789.
12. Durk T, Panther E, Muller T, Sorichter S, Ferrari D, Pizzirani C, et al (2005) 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol. 17: 599-606. (Pubitemid 41417857)
13. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL (1998) Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol. 161: 2586-2593. (Pubitemid 28397078)
14. Emerson M, Paul W, Page CP (1999) Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit. Br J Pharmacol. 127: 1652-1656. (Pubitemid 29369000)
15. Farmer P, Pugin J (2000) β-adrenergic agonists exert their 'anti-inflammatory' effects in monocytic cells through the IκB/NF-κB pathway. Am J Physiol Lung Cell Mol Physiol. 279: L675-L682.
16. Gao MX, Li KS, Dong J, Liege S, Jiang B (2000) Strain-dependent association between lateralization and lipopolysaccharide-induced IL-1β and IL-6 production in mice. Neuroimmunomodulation. 8: 78-82.
17. Hasko G, Szabo C, Nemeth ZH, Deitch EA (2002) Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol. 122: 34-39. (Pubitemid 34075488)
18. Hickey FB, Brereton CF, Mills KH (2008) Adenylate cyclase toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol. 84: 234-243. (Pubitemid 351960299)
19. Huang Y, Qiu AW, Peng YP, Liu Y, Huang HW, Qiu Y (2010) Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function. Neuroendcrinol Lett. 31: 725-864.
20. Ilani T, Strous RD, Fuchs S (2004) Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J. 18: 1600-1602. (Pubitemid 39561646)
21. Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, et al (2009) Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun. 23: 507-517.
22. Laengle U, Markstein R, Pralet D, Seewald W, Roman D (2003) Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Exp Eye Res. 83: 1335-1339U.
23. Levite M, Chowers Y, Ganor Y, Besser, M, Hershkovits R, Cahalon L (2001) Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol. 12: 3504-3512. (Pubitemid 34030963)
24. Levite M (2008) Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol. 8: 460-471.
25. Li H, He Y, Zhang J, Sun S, Sun B (2007) Lipopolysaccharide regulates toll-like receptor 4 expression in human aortic smooth muscle cells. Cell Biol. Int. 31: 831-835.
26. Li X, Jiang S, Tapping RI (2010) Toll-like receptor signaling in cell proliferation and survival. Cytokine. 49: 1-9.
27. Lindell DM, Berlin AA, Schaller MA, Lukacs NW (2008) B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. Plos ONE. 3: e3129.
28. Lund FE (2008) Cytokine-producing B lymphocytes - key regulator of immunity. Curr Opin Immunol. 20: 332-338.
29. Machado RA, Constantino L, Martins MR, de Albuquerque IM, Menna-Barreto S, Streck E, et al (2007) Lack of effect of dopaminergic antagonists in a rodent model of peritoneal sepsis. Cell Biol Int. 31: 1036-1041. (Pubitemid 46819078)
30. Matalka KZ (2003a) The effect of estradiol, but not progesterone, on the production of cytokines in stimulated-whole blood is concentration dependent. Neuroendocrinol Lett. 24: 185-191.
31. Matalka KZ, Tutunji MF, Abu-Baker M, Abu Baker Y (2005) Measurement of protein cytokines in tissues extracts by enzyme-linked immunosorbent assays: application to lipopolysaccharide-induced differential milieu of cytokines. Neuroendocrinol lett. 26: 231-236.
32. Matalka KZ (2003b) Prolactin enhances production of interferon-γ, interleukin-12 and interleukin-10, but not of tumor necrosis factor-α, in a stimulus specific manner. Cytokine. 21: 187-194.
33. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Browen-Jones D, et al (2002) Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol. 132: 34-40. (Pubitemid 35333323)
34. Milbrandt EB, Kersten A, Kong L, Weissfeld LA, Clermont G, Fink MP, et al (2005) Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 33: 226-229. (Pubitemid 40116563)
35. Missale C, Nash SR, Susan W, Robinson Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev. 78: 189-225. (Pubitemid 28070979)
36. Moots RJ, Al Saffar Z, Hutchinson D, Golding S, Young S, Baconet P, et al (1999) Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Ann Rheum Dis. 58: 585-587. (Pubitemid 29409107)
37. Moreno R, Afonso S, Fevereiro T (2006) Incidence of sepsis in hospitalized patients. Curr Infect Dis Rep. 8: 346-50.
38. Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J. Recept. Signal Transduct Res. 24: 165-205.
39. Pacheco R, Prado CE, Barrientos MJ, Bernales S (2009) Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol. 216: 8-19.
40. Pitossi F, del Rey A, Kabiersch A, Besedovsky H (1997) Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J Neurosci Res. 48: 287-298. (Pubitemid 27232703)
41. Pivonello R, Ferone D, Lombardi G, Colao A, Lamberts SWJ, Hofland LJ (2001) Novel insights in dopamine receptor physiology. Eu J Endocrinol. 156: S13-S21.
42. Platzer C, Docke W, Volk H, Prosch S (2000) Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol. 105: 31-38. (Pubitemid 30125426)
43. Saha B, Mondai AC, Majumder J, Basu S, Dasgupta PS (2001) Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism. Neuroimmunomodulation. 9: 23-33. (Pubitemid 32642070)
44. Sibley DR, Monsma Jr, FJ, Shen Y (1993) Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol. 35; 391-415.
45. Sidhu A (1998) Coupling of D1 and D5 dopamine receptors to multiple G proteins: implications for understanding the diversity in receptor-G protein coupling. Mol Neurobiol. 16: 125-134.
46. Song C, Lin A, Kenis G, Bosmans E, Maes M (2000) Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist. Schizophr Res. 42: 157-164. (Pubitemid 30163081)
47. Sriskandan S, Altmann DM (2008) The immunology of sepsis. J Pathol. 214: 211-223 (Pubitemid 351160158)
48. Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JPG, Smeets MB, et al (2002) In vivo evidence for a role of Toll-Like receptor 4 in the development of intimai lesions. Circulation. 106: 1985-1990.
49. Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, et al (2006) Dopamine selectively induces migration and homing of native CD8+ T cells via dopamine receptor D3. J Immunol. 176: 848-856. (Pubitemid 43099681)
50. Yang HM, Butterworth L, Munson AE, Meade BJ (2003) Respiratory exposure to diesel exhaust particles decreases the spleen IgM responses to a T cell-dependent antigen in female B6C3F1 mice. Toxicol Sci. 71: 207-216. (Pubitemid 36285013)
51. Yang M, Zhang H, Voyno-Yasenetskaya T, Ye RD (2003) Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation. Mol Pharmacol. 64: 447-455.